Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs USFD✓SelectedUSD · USFDMRNA vs USFD performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs USFD

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-31.0%
USFD return
+221.5%
Excess return
-252.5%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioUSFDExcessAlpha
1D-2.2%+0.5%-2.7%-2.4%
7D-12.7%-1.0%-11.7%-12.3%
30D-20.7%+5.1%-25.8%-22.3%
3M+46.3%-1.0%+47.3%+46.8%
6M+305.2%+32.3%+272.9%+258.3%
YTD+561.2%+42.5%+518.7%+452.7%
1Y+772.1%+53.2%+718.8%+603.6%
3Y+147.0%+150.6%-3.7%+54.6%
All-31.0%+221.5%-252.5%-60.0%

Cumulative growth

Daily Returns

Daily percentage return beside USFD.

Daily Out/Under-Performance

Portfolio return minus USFD return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × USFD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded USFD wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling